Founded in 2012, Blue Matter is a specialized management consulting firm serving the life sciences industry. The firm maintains offices across the United States and Europe. Blue Matter works to help pharmaceutical and biotechnology companies “maximize value at the product, portfolio, and company levels.” The firm’s services can be grouped into the following categories: New Product Planning, Launch Strategy and Management, Commercial Strategy for In-Line Products, and Organizational Design and Development. While most of Blue Matter’s work involves pre-launch and launch products, the firm does not exclusively focus there. It works across a range of therapeutic areas, but has developed specialized capabilities in oncology and rare diseases.

April 30, 2019

Blue Matter Launches New Company, Salience Learning

Blue Matter is pleased to announce the launch of a new, wholly-owned subsidiary, Salience Learning. The new company is a learning and development (L&D) firm focused on the life sciences.

The Salience Learning team includes experts in adult education, as well as life science industry veterans.  Using this combination of expertise, the company applies science-based educational approaches to help life science companies solve their most complex business challenges.

The company’s offerings are designed to help industry professionals elevate critical thinking skills, operate more effectively in matrixed environments, leverage data more effectively to drive business results, and improve business acumen. The firm also helps improve the effectiveness of L&D organizations.

March 19, 2018

Blue Matter Announces Key Promotions

Blue Matter is pleased to announce two key promotions: George Schmidt to Managing Partner and Tom Quirk to Partner. Both are leaders in Blue Matter’s European operation and have been instrumental in expanding the firm’s presence there.